In contrast, some studies have shown that patients with hepatocellular carcinoma with high levels of ACE-2 had a longer survival time [44], whereas other studies have suggested that decreased ACE-2 may be suggestive of cancer in a diabetic patient [46]. The gene discussed is ACE2; the disease is cancer.